Shamim Ruff, SVP, Regulatory Affairs & Qual at Sarepta Therapeutics, Inc. (SRPT), sold 11,500 shares at $50.00 ($575K) on 2017-10-03, disclosed to the SEC on 2017-10-05.
Open-market sale of $575k SRPT by SVP, Regulatory Affairs & Qual. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SRPT | SELL | 2017-11-08 | $550K | — | Filing → |
| SRPT | SELL | 2017-07-21 | $522K | — | Filing → |
| SRPT | SELL | 2016-09-30 | $439K | — | Filing → |